Organogenesis Holdings Inc.

ORGO · Nasdaq · SIC 2834: Pharmaceutical Preparations
175
SEC Filings

Business Summary

3 Item 1A. Risk Factors 15 Item 1B. Unresolved Staff Comments 48 Item 1C. Cybersecurity 48 Item 2. Properties 48 Item 3. Legal Proceedings 49 Item 4. Mine Safety Disclosures 49 PART II Item 5. Market For Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 50 Item 6. Reserved 51 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 52 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 63 Item 8. F...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionORGOdiscussed_in_filing Cybersecurity
topic_mentionORGOdiscussed_in_filing Cybersecurity
topic_mentionORGOdiscussed_in_filing Cybersecurity
topic_mentionORGOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076730EDGAR78K words
2025-02-272024-12-310000950170-25-029137EDGAR—
2024-02-292023-12-310000950170-24-023150EDGAR—
2023-03-012022-12-310000950170-23-005585EDGAR—
2022-03-012021-12-310001193125-22-061686EDGAR—
2021-03-162020-12-310001193125-21-082849EDGAR—
2020-03-092019-12-310001193125-20-067198EDGAR—
2019-03-182018-12-310001193125-19-078332EDGAR—
2018-03-142017-12-310001558370-18-002068EDGAR—
2017-03-282016-12-310001047469-17-002096EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269697EDGAR25K words
2025-08-072025-06-300000950170-25-105048EDGAR—
2025-05-082025-03-310000950170-25-066962EDGAR—
2024-11-122024-09-300000950170-24-125431EDGAR—
2024-08-082024-06-300000950170-24-094009EDGAR—
2024-05-092024-03-310000950170-24-057050EDGAR—
2023-11-092023-09-300000950170-23-062056EDGAR—
2023-08-092023-06-300000950170-23-040670EDGAR—
2023-05-102023-03-310000950170-23-020627EDGAR—
2022-11-092022-09-300000950170-22-023947EDGAR—
2022-08-092022-06-300000950170-22-016142EDGAR—
2022-05-102022-03-310001193125-22-146366EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076595EDGAR8K words
2026-02-230001193125-26-064270EDGAR—
2025-12-290001193125-25-335425EDGAR—
2025-11-060001193125-25-269654EDGAR—
2025-09-250001193125-25-217810EDGAR—
2025-08-070000950170-25-105032EDGAR—
2025-06-240001193125-25-145767EDGAR—
2025-05-080000950170-25-066930EDGAR—
2025-03-270001193125-25-065638EDGAR—
2025-02-270000950170-25-029021EDGAR—

175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001661181
TickerORGO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: eb73df8a7bdc903cac4601124ea922cb7eb52dfed7fca9fc05a1ee02bed6999e
parent: 287fc451e321e5fa343c7439f26ff5f194eeaab580b05a4cdc46be0102b9cada
content hash: 2fd7ed45d204b117bb6fdc80974d6b17c405e7d14bcf79711c78e2672ae6926e
signed: 2026-04-13T04:46:45.201Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf